Latest news and press releases about Stryker Corporation (SYK): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries.
Price
| Price | $285.22 |
| Market Cap | $109.3B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 28.54 |
| Price / Book | 4.40 |
| EV / EBITDA | 23.23 |
| Dividend Yield | 1.28% |
Profitability
| Return on Equity | 14.48% |
| Return on Invested Capital | 8.53% |
| Return on Assets | 6.78% |
| Gross Margin | 65.17% |
| Operating Margin | 22.03% |
| Net Margin | 14.43% |
Related companies: AMGN · BSX · DHR · GILD · HCA · MCK · MDT
Explore sector: Healthcare · Medical - Devices
More sections of SYK: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks